Business Context and Reporting Period
CollPlant Biotechnologies Ltd. filed Form 6-K on July 11, 2019, for the month of July 2019. The filing announces a corporate action involving a reverse share split and a corresponding adjustment to the American Depositary Share (ADS) ratio.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes.
Material Changes
- Reverse Share Split: Ordinary shares are being consolidated at a ratio of 1-for-50. Each 50 ordinary shares (par value NIS 0.03) will become one ordinary share (par value NIS 1.50).
- ADS Ratio Adjustment: The ratio of ADSs to ordinary shares changes from 1 ADS representing 50 ordinary shares to 1 ADS representing 1 ordinary share.
- Share Capital Reduction: Registered share capital will be reduced to 15 million ordinary shares.
- Outstanding Shares: The number of outstanding ordinary shares will be reduced to approximately 3.8 million.
- Trading Resumption: ADSs will begin trading on the Nasdaq Capital Market under the new structure on Monday, July 15, 2019.
Guidance, Outlook, and Risks
Management states that because the ADS to ordinary share ratio is reduced on the same proportionate basis as the reverse split, no overall effect on the ADS share price is expected. No action is required by ADS holders. The filing does not provide forward-looking guidance, risk factors, or contingencies beyond the mechanics of the split.
Investor Verification Checklist
- Confirm the effective date of the reverse split and ADS ratio change (July 15, 2019).
- Verify the new par value of ordinary shares (NIS 1.50).
- Check the treatment of fractional shares (rounded to the nearest whole share; holders of less than half a consolidated share receive nothing).
- Review the updated number of outstanding shares (approx. 3.8 million).